MHRA approves orforglipron weight-loss pill The Medicines and Healthcare products Regulatory Agency said its approval of orforglipron makes the UK the first country in Europe to authorise the medication.…
UK patients being recruited for ribupatide trials Researchers will assess the efficacy of up to 10mg doses of weight-loss drug ribupatide in patients with or without diabetes over around an 18-month period.…
Government did not conduct impact assessment for community pharmacy prescribing Exclusive: The Department of Health and Social Care told The Pharmaceutical Journal that changes under the ‘Community pharmacy contractual framework’ for 2026/2027 and other years since 2023 did not reach the threshold for an impact assessment.…
Antihistamine prescribing increased by 18% in five years NHS Business Services Authority data also show that fexofenadine has been the most commonly prescribed and dispensed antihistamine in the community in England since 2021/2022.…
Incretin-based weight-loss drugs should not be deliberately continued in pregnancy, consensus guidelines state The guidelines have been drawn up by a multidisciplinary group of experts following a systematic scoping review.…
Delivery of 90,000 meningitis B vaccinations for young people prompts call for annual campaign During the first week of the NHS meningococcal B disease vaccination service, more than 8,200 participating pharmacies received around 135,000 bookings.…
Once-weekly HIV pill performs as well as daily treatment in phase III study Researchers found that a once-weekly tablet combining islatravir and lenacapavir performed as well as the once-daily bictegravir–emtricitabine–tenofovir alafenamide regimen.…
Local authorities advised to work with pharmacies to improve rural vaccination rates The Local Government Association said that community pharmacies should engage with local directors of public health to close gaps in vaccination coverage.…
Prescribing of dependency forming medicines ‘moving in the right direction’ but challenges remain NHS Business Services Authority data reveals that in 2025/2026, the number of prescriptions for opioids decreased by 8% compared with 2016/2017.…
Around one in five adults would share weight-loss jabs with friends, survey finds A Pharmacy2U-commissioned survey also found that more than one-quarter of UK adults said that they would share oral weight-loss medication with friends or family.…